Last updated on July 2019

Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease


Brief description of study

The primary objective of the study is to evaluate the efficacy of AGB101 on slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with mild cognitive impairment due to Alzheimer's Disease (MCI due to AD) also known as prodromal AD. Participants will be randomized to receive placebo or AGB101 (220 mg), once daily for 78 weeks. Secondary objectives are to assess the effect of AGB101 compared with placebo on clinical progression as measured by Mini-Mental State Examination (MMSE) and Functional Activities Questionnaire (FAQ).

Clinical Study Identifier: NCT03486938

Find a site near you

Start Over

Excell Research Inc

Oceanside, CA United States
  Connect »

Chase Medical Research LLC

Waterbury, CT United States
  Connect »

Brain Matters Research

Delray Beach, FL United States
  Connect »

Bioclinica Research

Melbourne, FL United States
  Connect »

IMIC Research

Palmetto Bay, FL United States
  Connect »

The Roskamp Institute, Inc

Sarasota, FL United States
  Connect »

NeuroStudies.net, LLC

Decatur, GA United States
  Connect »

Clinical Trials of Texas, Inc

San Antonio, TX United States
  Connect »

Senior Clinical Trials, Inc.

Laguna Hills, CA United States
  Connect »

Care Access Research, Santa Clarita

Santa Clarita, CA United States
  Connect »

MD Clinical

Hallandale Beach, FL United States
  Connect »

Miami Jewish Health

Miami, FL United States
  Connect »

Great Lakes Clinical Trials

Chicago, IL United States
  Connect »

Richmond Behavioral Associates

Staten Island, NY United States
  Connect »

Bioclinica Research

Orlando, FL United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.